Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

849217-60-3N-(4-Fluorophenyl)-N'-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide

● Auf Lager

Katalog-Nr.::	VE0010596
CAS-Nr.::	849217-60-3
Summenformel::	C17H15FN2O3
Molare Masse::	314.31 g/mol

Angebot anfordern

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 849217-60-3

Parent drug

Cabozantinib

IUPAC-Name

N-(4-Fluorophenyl)-n‘-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide

Pharmacopeial Synonyms

N/A

Synonyme

Cabozantinib Hydroxy Impurity; Cabozantinib Impurity 7

SMILES

O=C(C1(C(NC2=CC=C(O)C=C2)=O)CC1)NC3=CC=C(F)C=C3

InChI

InChI=1S/C17H15FN2O3/c18-11-1-3-12(4-2-11)19-15(22)17(9-10-17)16(23)20-13-5-7-14(21)8-6-13/h1-8,21H,9-10H2,(H,19,22)(H,20,23)

Beschreibung

N-(4-Fluorophenyl)-N‘-(4-hydroxyphenyl)cyclopropane-1,1-dicarboxamide is a well-characterized reference material that meets stringent regulatory standards set by USP, EMA, JP, and BP. It plays a key role in Abbreviated New Drug Applications (ANDA), New Drug Applications (NDA), and the commercial production of Cabozantinib.